跳至主要内容
临床试验/TCTR20221130004
TCTR20221130004已完成3 期

Efficacy of As-Needed Pilocarpine for the Treatment of Radiation-Induced Xerostomia: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study

Ratchadapisek Pageant Research Fund0 个研究点目标入组 20 人开始时间: 2022年11月30日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age 18 years old and above
  • 2. Diagnosed with head and neck cancer
  • 3. Underwent radiotherapy (IMRT or 3D-CRT technique) more than 6 months prior to entering this study
  • 4. History of xerostomia
  • 5. Clinical Oral Dryness Score 3 and above
  • 6. Can understand Thai
  • 7. Able to attend follow-up visits
  • 8. Consent to be in the study

排除标准

  • 1. Pilocarpine allergy
  • 2.Autoimmune disease
  • 3.Patient with current medications affecting salivary flows
  • 4. Patient with swallowing proble or currently using nasogastric tube feeding
  • 5.Patient with current use of pilocarpine or other sialogogue within 1 month prior to the study
  • 6. Pregnant woman and lactating woman
  • 7. Patient underwent oral surgery and salivary gland surgery

研究者

发起方
Ratchadapisek Pageant Research Fund

相似试验